1. Home
  2. INBS vs SPHL Comparison

INBS vs SPHL Comparison

Compare INBS & SPHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.69

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo Springview Holdings Ltd Class A Ordinary Shares

SPHL

Springview Holdings Ltd Class A Ordinary Shares

N/A

Current Price

$2.46

Market Cap

7.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
SPHL
Founded
2016
2002
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical Specialities
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.1M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
INBS
SPHL
Price
$1.69
$2.46
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
30.9K
★ 2.0M
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $1,980,484.00
N/A
Revenue This Year
$44.72
N/A
Revenue Next Year
$44.26
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.36
52 Week High
$24.90
$25.11

Technical Indicators

Market Signals
Indicator
INBS
SPHL
Relative Strength Index (RSI) 49.82 49.49
Support Level $1.52 $2.33
Resistance Level $1.92 $2.98
Average True Range (ATR) 0.10 0.46
MACD 0.04 0.02
Stochastic Oscillator 80.95 11.73

Price Performance

Historical Comparison
INBS
SPHL

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About SPHL Springview Holdings Ltd Class A Ordinary Shares

Springview Holdings Ltd conducts its operations through its indirect wholly-owned subsidiary, which designs and constructs residential and commercial buildings in Singapore. It also provides four main types of work, including new construction, reconstruction, Additions and Alterations (A&A), and other general contracting services such as renovation and design consultation. The company operates and manages its business as a single segment in the development of construction projects. It derives maximum revenue from its Residential Customers.

Share on Social Networks: